Literature DB >> 7565305

DNA index and %S-phase cells determined in acute lymphoblastic leukemia of children: a report from studies ALL V, ALL VI, and ALL VII (1979-1991) of the Dutch Childhood Leukemia Study Group and The Netherlands Workgroup on Cancer Genetics and Cytogenetics.

L A Smets1, R Slater, E R van Wering, A van der Does-van den Berg, A A Hart, A J Veerman, W A Kamps.   

Abstract

DNA per cell content was routinely recorded by single-parameter flow cytometry in leukemic blasts from 473 children with acute lymphoblastic leukemia (ALL), enrolled in national studies ALL V, VI, and VII (1979-1991) of the Dutch Childhood Leukemia Study Group. The parameters bonemarrow %S-value and DNA Index were compared with clinical features, with chromosome number based on cytogenetic analyses and with treatment results in study ALL VI. %S-values, ranging between 1 and 36%, were unrelated to initial white blood cell count, immunophenotype, and DNA index but were lowest in blasts with L1 morphology. In study ALL VI (non-high risk), the survival of patients with < or = 6% S-phase cells was superior to that of patients with %S-values of > 6 (P = 0.030). Hyperdiploidy, defined by a DNA index > or = 1.16, was compared to the cytogenetic hyperdiploid classification of n > 50. Initially there were 25 discrepancies in 189 samples jointly analysed by flow cytometry and cytogenetics. After review only five discrepancies remained unresolved. Hyperdiploidy, independent of the method used, was found to be unrelated to blast morphology and %S-phase cells but closely associated with c-ALL and was absent in T-ALL. In study ALL VI, event-free survival at 8 years of hyperdiploid patients was 90.6% but was not significantly different from non-hyperdiploid patients (EFS = 82.1%; P = 0.08). Routine DNA flow cytometry appeared a valuable adjunct to cytogenetic analyses and allowed the identification of a large subset of non-high-risk ALL patients in study ALL VI with a DNA index > or = 1.16 or %S-value of < or = 6.0 with highest survival probability.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565305     DOI: 10.1002/mpo.2950250604

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  5 in total

1.  Chromatin-bound PCNA as S-phase marker in mononuclear blood cells of patients with acute lymphoblastic leukaemia or multiple myeloma.

Authors:  F Zölzer; O Basu; P U Devi; S P Mohanty; C Streffer
Journal:  Cell Prolif       Date:  2010-12       Impact factor: 6.831

Review 2.  Advances and issues in flow cytometric detection of immunophenotypic changes and genomic rearrangements in acute pediatric leukemia.

Authors:  Xin Maggie Wang
Journal:  Transl Pediatr       Date:  2014-04

3.  Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.

Authors:  P Kaaijk; G J L Kaspers; E R Van Wering; G J Broekema; A H Loonen; K Hählen; K Schmiegelow; G E Janka-Schaub; G Henze; U Creutzig; A J P Veerman
Journal:  Br J Cancer       Date:  2003-03-10       Impact factor: 7.640

4.  DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy.

Authors:  Silvia Carloni; Giulia Gallerani; Anna Tesei; Emanuela Scarpi; Giorgio Maria Verdecchia; Salvatore Virzì; Francesco Fabbri; Chiara Arienti
Journal:  Onco Targets Ther       Date:  2017-09-20       Impact factor: 4.147

5.  Flow Cytometric DNA Ploidy Analysis in Haemato-Lymphoid Neoplasms: An Analysis of 132 Cases.

Authors:  Nishit Gupta; Aditi Mittal; Tina Dadu; Dharma Choudhary; Anil Handoo
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2022-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.